Why is Aspira Pathlab falling/rising?

As of 18-Jul, Aspira Pathlab & Diagnostics Ltd's stock price is currently at Rs 52.55, reflecting an increase of Rs 1.03 or 2.0%. Despite opening with a loss of 2% today, the stock managed to touch an intraday high of Rs 52.55, indicating some recovery during the trading session. However, it is important to note that the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which suggests a bearish trend in the short term. The stock has outperformed its sector by 2.54% today, but it has experienced a decline of 1.78% over the past week and a significant drop of 9.35% over the past month. On a positive note, the company has reported strong financial results, with net sales growing by 53.71% and profits increasing by 177.5% over the past year, contributing to a substantial annual return of 67.52%.
In the broader market context, while the stock has shown impressive performance over the past year, the benchmark Sensex has only increased by 0.51% during the same period. This indicates that Aspira Pathlab has significantly outperformed the market overall. However, the recent weak investor participation, with delivery volume dropping by 86.94% against the 5-day average, raises concerns about the stock's liquidity and investor confidence. Additionally, the company's long-term fundamental strength appears weak, with a poor EBIT to Interest ratio and a relatively low CAGR growth in operating profits over the last five years. These factors may contribute to the stock's volatility and mixed performance in the short term.